Asset Management Corp Seelos Therapeutics, Inc. Transaction History

Asset Management Corp

$146 Million
Q1 2023

A detailed history of Asset Management Corp transactions in Seelos Therapeutics, Inc. stock. As of the latest transaction made, Asset Management Corp holds 40,500 shares of SEEL stock, worth $7,695. This represents 0.02% of its overall portfolio holdings.

Number of Shares

40,500

Holding current value

$7,695

% of portfolio

0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$0.59 - $1.04 $23,895 - $42,120	40,500 New	40,500 $27,000
Q3 2022 Oct 21, 2022	BUY	$0.65 - $278.68 $14,625 - $6.27 Million	22,500 Added 97.83%	45,500 $47,000
Q2 2022 Aug 01, 2022	BUY	$0.51 - $0.93 $11,730 - $21,390	23,000 New	23,000 $16,000
Q1 2022 May 03, 2022	SELL	$0.84 - $1.71 $8,400 - $17,100	-10,000 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$1.59 - $2.38 $46,905 - $70,210	-29,500 Reduced 74.68%	10,000 $16,000
Q3 2021 Oct 13, 2021	BUY	$1.69 - $2.89 $21,125 - $36,125	12,500 Added 46.3%	39,500 $95,000
Q2 2021 Aug 06, 2021	SELL	$2.64 - $6.32 $34,320 - $82,160	-13,000 Reduced 32.5%	27,000 $71,000
Q1 2021 May 04, 2021	SELL	$1.35 - $4.99 $54,927 - $203,028	-40,687 Reduced 50.43%	40,000 $200,000
Q4 2020 Jan 29, 2021	BUY	$0.74 - $2.01 $59,708 - $162,180	80,687 New	80,687 $130,000

Others Institutions Holding SEEL

# of Institutions

Shares Held

40.5K

Call Options Held

Put Options Held

View Full List

About SEELOS THERAPEUTICS, INC.

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $20.3M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

More about SEEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Corp with notifications on news.

Account